LIMITED STOCK AVAILABLEPRICES SHOWN WHERE AVAILABLE
MOTS-C

CELLULAR / SINGLE

MOTS-C

10MG · 40MG
Important medical and research notice

This content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.

Research Overview

A mitochondrial-derived peptide studied in cellular-energy and metabolic-signalling models.

Available Strengths

  • 10MG (MS10)
  • 40MG (MS40)

Research Protocol

Reference gradual schedule

PeriodDoseU-100 unitsVolume
Weeks 1–20.2 mg60.06 mL
Weeks 3–40.4 mg120.12 mL
Weeks 5–60.6 mg180.18 mL
Weeks 7–80.8 mg240.24 mL
Weeks 9–10+1 mg300.3 mL

Reconstitution

Water volume3 mLConcentration3.33 mg/mLAdministrationSubcutaneousFrequencyOnce dailyCycle length8–12 weeks in the reference protocol, optionally extended to 16 weeks.

≈3.33 mg/mL once reconstituted

  1. Draw 3.0 mL of bacteriostatic water per 10 mg vial.
  2. Inject slowly along the vial wall; swirl gently until dissolved.

Research context

Discussed as activating AMPK via folate-cycle inhibition, shifting cells toward energy-efficient metabolism; also described as translocating to the nucleus under stress to support antioxidant gene expression.

Storage

−20°C or below, dry and dark. 2–8°C, use within 7 days, avoid freeze-thaw cycles.

Research Notes

  • For educational and research reference only. Not medical advice and not intended for unsupervised human use.
  • Human dosing, efficacy and long-term safety are not established in the cited literature.

References

Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source